To determine the impact of WT versus HuR-KO EVs in HuR-KO tumor-bearing mice, we tested whether PDAC EVs would be imported by PDAC and stromal cells in the TME when administered intraperitoneally or intravenously (Supplementary Fig. S6A). Here, ELAVL1 is linked to neoplasm.